Nationwide Class For Vioxx Suit Rejected

Law360, New York (September 6, 2007, 12:00 AM EDT) -- Handing Merck & Co. a victory, the New Jersey Supreme Court on Thursday reversed a lower court ruling that certified a nationwide class of Vioxx consumers attempting to get back the money they spent on the drug.

The supreme court cited two reasons for rejecting the certification of a nationwide class of insurance companies and other third-parties. The claims of the third-party payors involved different questions of fact or law, and a class action in this case would not be superior to other available methods of...
To view the full article, register now.